Back to discover
Drug

Taurine

In clinical development
Emerging researchLate-stage developmentRising momentum
Also known as Aminoethylsulfonic acid, Aminosyn-PF 10 %, Sulfite-Free, Aminosyn-PF 7%, PremaSol+5 more

Aminoethylsulfonic acid, Aminosyn-PF 10 %, Sulfite-Free, Aminosyn-PF 7%, PremaSol, Taurine-Vitamin B6, Taurineold, Trophamine, Trophamine 10 %, Trophamine 6 %.

3
Research papers
5
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Taurine Supplementation as a Novel Therapeutic Approach for Neurocognitive Symptoms in Long COVID

Clinical trial2026-05-27Results expected Q1 2028 · ClinicalTrials.gov

Taurine Affects the Progression of Senile Cataract: a Single-arm Pre-post Intervention Study

Clinical trial2024-12-20Primary completion · ClinicalTrials.gov

Taurine deficiency as a driver of aging.

Research2023-06-09Science (New York, N.Y.)

Taurine for Early Left Ventricular Recovery in Peripartum Cardiomyopathy

Clinical trial2020-01-01Completed · ClinicalTrials.gov

Oxidative Stress Markers In Inherited Homocystinuria And The Impact Of Taurine

Clinical trial2018-07-09Results posted · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Taurine
Aliases & brands
Aminoethylsulfonic acidAminosyn-PF 10 %, Sulfite-FreeAminosyn-PF 7%PremaSolTaurine-Vitamin B6TaurineoldTrophamineTrophamine 10 %Trophamine 6 %
RxNorm CUI
10337
ChEMBL ID
CHEMBL239243
UNII
1EQV5MLY3D

Clinical trials

16 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
16
registered trials across all phases
LATEST COMPLETION 2021
5
Active studies
4
Recruiting
8
Late-stage (III+)
6
Completed
5
Discontinued
PHASE DISTRIBUTIONn = 16
Phase 11Phase 1 / 24Phase 23Phase 2 / 33Phase 41Phase N / A4

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

3 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20202024
Major research themes4
Aging2Taurine2Dietary Supplements1Neuronal Plasticity1
Journals, researchers & institutions
Top journals
  • Amino acids1
  • Science (New York, N.Y.)1
  • Scientific reports1
Leading researchers
  • Ali AM1
  • Andersen JK1
  • Baumert P1
  • Biswal BK1
  • Chamoli M1
  • Charzynska A1
  • Chattopadhyay N1
  • Chawla AS1
Leading institutions
free-text, unnormalised
  • Broad Institute of Harvard and MIT1
  • Buck Institute for Research on Aging1
  • Centre for Healthy Longevity1
  • Columbia University1
  • Columbia University Irving Medical Center1
  • CSIR-Central Drug Research Institute1

Related drugs

3 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across the same disease area as Taurine in the shared literature.

1 shared disease1 shared paper

Frequently co-studied with Taurine in the research literature.

1 shared paper

Frequently co-studied with Taurine in the research literature.

1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials